Das Kloster
Mürgstrasse 18
CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
media@mondobiotech.com
Stans, Switzerland
mondoBIOTECH’s Chief Scientific Officer and cofounder Dr. Dorian Bevec will present the company at the upcoming 10th Annual Biotech in Europe Investor Forum on Wednesday, September 29th, 2010 at 3:15 p.m. at the Zurich Airport Radisson Blu Hotel, Room Lucerne, Level 7.
Stans, Switzerland
mondoBIOTECH holding AG (SIX: RARE) announces today that the United States FDA has granted the Orphan Drug Designation for the treatment of Chronic Beryllium Disease to its medicinal product candidate, the human peptide DasKloster0210.
Stans, Switzerland
mondoBIOTECH holding AG (SIX: RARE) announces today that Dr. Dorian Bevec, Chief Scientific Officer and co-founder, will present at the upcoming 3rd Annual International Partnering Conference BioPharm America 2010 on Thursday, September 16th, 2010 at 2 p.m. eastern time / 6 p.m. local time in the Clarendon Room at the Marriott Boston Copley Place in Boston.
Stans, Switzerland
- Mondobiotech
- Fast fact
- Overview
- Milestones
- Board of Directors
- Management
- Location
- Products
- Product Overview
- Types of products
- Pipeline
- Rare Diseases
- About Rare Diseases
- Patient and Families
- Rare Diseases List
- Media Archive
- Investor
- Financial Information
- Key Information
- Corporate Governance
- Appointments
- Partnership
- Pipeline
- Science
- Pipeline
- Product Overview
- Research Vision